Why the study?
Pulmonary embolism is common and potentially fatal, with evolving diagnostic, risk assessment, and therapeutic options alongside ongoing clinical controversies.
This review highlights updates in pulmonary embolism management, including the use of adjusted D-dimer thresholds, DOACs for outpatient management, and reserving systemic thrombolysis for hemodynamically unstable patients.
No takes yet. Share an insight, caveat, or question.
May support DOAC preference and selective thrombolysis in VTE; leaves open strategies to address chronic functional limitations in half of patients.
Duffett et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: